Delivery Order SPE2DB24D1104-SPE2DB25FYAK2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,187.90 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Durolane 60 mg/3 mL syringes. The contract, which is not set-aside and was competitively awarded, is classified as a firm fixed price delivery order with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $1,275.20. This is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, representing a single-dose pharmaceutical delivery. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Durolane 60 mg/3 ml syringes at a ceiling value of $1,275.20. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's location...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $3,523.79 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Durolane 60 mg/3 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a $3,054.39 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $6,262.11 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's broader...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYAK2Delivery Order
The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $6,899.84. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been competitively selected to supply this pharmaceutical product as part of its comprehensive role as a global pharmaceutical support vendor for the Department of Defense. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across the military healthcare system, including specialty medications, vaccines, and medical devices. As a child contract under the broader SPE2DX vehicle, this delivery order enables the Defense Logistics Agency to procure critical pharmaceutical supplies to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 4/28/25 |